Back to LYEL
Point72 Asset Management, L.P. → LYEL
Point72 Asset Management, L.P. LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
5
Latest value
$558K
Q3 2026
Peak value
$558K
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $15K |
| Q4 2025 | $353K |
| Q1 2026 | $427K |
| Q2 2026 | $366K |
| Q3 2026 | $558K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $558K | 57.0K | — | — |
| Q2 2026 | $366K | 26.1K | — | — |
| Q1 2026 | $427K | 21.3K | — | — |
| Q4 2025 | $353K | 11.5K | — | — |
| Q1 2024 | $15K | 6.8K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M